Table 7.
Linear Regression Model for production and dissemination of evidence*
| Production and dissemination of evidence | ||
|---|---|---|
| Beta (Standard Error) | P-Value | |
| Constant | 0.786 (0.348) | 0.026 |
| Frequency of undertaking each of these knowledge transfer and exchange activities related to contact and exchange with health policymakers and stakeholders | ||
| 1- Interacted with credible messengers/sources (i.e., people who are not researchers but are seen by policymakers and stakeholders as credible sources of research) to promote use of evidence from HPSR and/or your own research | 0.017 (0.057) | 0.825 |
| 2- Developed relationships with print, radio and/or television journalists to promote use of evidence from HPSR and/or your own research. | 0.071 (0.065) | 0.398 |
| 3- Participated in meetings for presentation of results from HPSR and/or your own research to health policymakers and stakeholders. | 0.172 (0.064) | 0.058 |
| 4- Tried to involve policymakers and stakeholders but had difficulty contacting them. | 0.087 (0.048) | 0.211 |
| 5- Provided technical assistance to policymakers and stakeholders through short-term work through expert advisory committees, conferences, or forums. | 0.033 (0.075) | 0.766 |
| 6- Provided technical assistance through long- term formal collaborations between your institution and policymakers and stakeholders for sustained technical capacity development. | -0.025 (0.078) | 0.824 |
| 7- Interacted with health policymakers and stakeholders through informal conversations with personal contacts. | 0.053 (0.064) | 0.526 |
| 8- Interacted with health policymakers and stakeholders as part of a priority-setting process to identify high-priority health policy issues and research themes. | 0.364 (0.084) | 0.001 |
| 9- Involved policymakers and stakeholders in your research (in the development of joint proposals/research methodology and tools/analysis & write-up/publications). | 0.019 (0.064) | 0.833 |
| 10- Actively participated in health policy development committees or technical committees that help in decisionmaking. | 0.121 (0.059) | 0.161 |
| 11- Trained health policymakers and stakeholders to acquire, assess, interpret, and apply health research findings. | 0.19 (0.057) | 0.023 |
| Investments/resources available to you for the production and transfer and exchange of evidence from HPSR | ||
| 1. National funding is available for undertaking HPSR. | 0.125 (0.064) | 0.154 |
| 2- Regional funding is available for undertaking HPSR. | -0.12 (0.073) | 0.181 |
| 3- International funding is available for undertaking HPSR. | 0.105 (0.074) | 0.202 |
| 4- Funding sources (e.g., granting agencies) encourage knowledge transfer and exchange activities. | -0.08 (0.06) | 0.234 |
| 5- Funders formulate their priorities and calls for proposals in response to national and regional needs. | 0.072 (0.063) | 0.359 |
| 6- Policymakers and stakeholders provide adequate funding for priority research. | -0.049 (0.065) | 0.55 |
| 7- Policymakers and stakeholders clearly articulate priorities for health systems and policy research. | -0.009 (0.076) | 0.92 |
| 8- Incentives for knowledge transfer and exchange are available (e.g., performance incentives for knowledge transfer and exchange and proper criteria of promotion) within your organization. | -0.064 (0.054) | 0.342 |
| Adjusted R2 | 0.634 | |
| F | 11.040 | |
| P-value | < 0.001 | |
| N | 110 | |
† Beta stands for the average change in the score of the dependant variables per unit increase in independent variable scores.
* Results in bold are statistically significant at 0.05 level
HPSR: health policy and systems research